Insulin aspart, recombinant Subcutaneous and Pancreatin 4X
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pancreatin 4X and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: pancreatin
Brand name: Hi-Vegi-Lip, Pancreatin 4X, Pan-2400, Donnazyme, Digipepsin
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Pancreatin Capsules and Tablets
- Insulin aspart, recombinant Subcutaneous-Pancreaze
- Insulin aspart, recombinant Subcutaneous-Pancrelipase
- Insulin aspart, recombinant Subcutaneous-Pancrelipase Capsules
- Insulin aspart, recombinant Subcutaneous-Pancrelipase Tablets
- Insulin aspart, recombinant Subcutaneous-Pancuronium
- Pancreatin 4X-Insulin degludec
- Pancreatin 4X-Insulin Degludec (U-100) Prefilled Pens
- Pancreatin 4X-Insulin Degludec (U-100) Vials
- Pancreatin 4X-Insulin Degludec (U-200) Prefilled Pens
- Pancreatin 4X-Insulin degludec and liraglutide
- Pancreatin 4X-Insulin degludec and liraglutide Subcutaneous